Partner Courses
Immunological Therapies : Antibodies – Cytokines – Vaccines – Transplantation and Cell Therapy
This university program is part of the Graduate School Innovative Therapies in Cancerology at Université Paris Cité, linking master's and doctoral courses to cutting-edge research laboratories. The Graduate School offers cross-disciplinary training in immunology, hematology, and oncology.
Staff and students at the Institut Pasteur and its Pasteur Network benefit from preferential rates for enrolment at Paris Cité University (FPCPA rate of €450, excluding application fees)
Apllication on C@nditOnLine Référence formation : DUB121 (online)
Practical Information
- 1 samedi par mois en distanciel
- October 10, 2026 - April 24, 2027
-
Online
- French
Contacts
veronique.hamelin@aphp.fr
Registration
Accreditations:
- University Diploma (DU) - Université Paris Cité
Description
Objectives
- Understand the rationale for using immunotherapy in clinical practice.
- Learn about the advantages and disadvantages of different approaches to immunotherapy.
- Learn about the main indications for immunotherapy today.
- Discuss avenues for research in immunotherapy.
Targeted skills
By the end of the training, trainees will be able to
- Gaining a better understanding of the different classes of immunomodulatory drugs and their indications
- Manage their side effects
- Understand the mechanisms of action of these drugs
More information
Students will have a free access to the program for the JSIC 2025 Journées Scientifiques Immunité et Cancer.
Directors
DRAGON-DUREY Marie-agnès * - UPCité et AP-HP
PAGES Franck * - UPCité et AP-HP
TARTOUR Eric * - UPCité et AP-HP
Members of the course committee
DI SANTO James - Institut Pasteur
DRAGON-DUREY Marie-agnès * - UPCité et AP-HP
GONNIN Cécile * - UPCité et AP-HP
MASSE-RANSON Guillemette - Institut Pasteur
PAGES Franck * - UPCité et AP-HP
SALA Monica - Institut Pasteur
TARTOUR Eric * - UPCité et AP-HP
* Representative of Universities